Clinical Research Directory
Browse clinical research sites, groups, and studies.
Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis
Sponsor: Tanta University
Summary
This prospective interventional study aims to evaluate the effects of baricitinib on disease activity, lipid profile, atherogenic index, and procoagulant biomarkers including monocyte-derived human tissue factor and D-dimer in patients with rheumatoid arthritis, compared with conventional therapy.
Official title: Prospective Evaluation of Baricitinib's Effects on Procoagulant State and Atherogenic Index in Rheumatoid Arthritis Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-01
Completion Date
2026-12
Last Updated
2026-01-22
Healthy Volunteers
Yes
Conditions
Interventions
Baricitinib
Oral baricitinib administered in combination with methotrexate according to standard clinical practice
Locations (1)
Tanta University Hospitals
Tanta, Egypt